RituximabPneumonia following off label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1779卷 / 1期

关键词：

D O I：

10.1007/s40278-019-71471-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：207 / 207

相关论文

共 50 条

[11] CediranibPolycythaemia following off label use : case report
Reactions Weekly, 2020, 1796 (1) : 68 - 68
[12] GadobutrolNeurotoxicity following an off label use: case report
Reactions Weekly, 2019, 1773 (1) : 169 - 169
[13] MetreleptinHypoglycaemia following off label use: case report
Reactions Weekly, 2022, 1924 (1) : 287 - 287
[14] CidofovirTubulopathy following off label use: case report
Reactions Weekly, 2018, 1731 (1) : 81 - 81
[15] LomitapideDiarrhoea following off label use: case report
Reactions Weekly, 2019, 1763 (1) : 214 - 214
[16] RituximabHypogammaglobulinaemia following off label use: case report
Reactions Weekly, 2023, 1963 (1) : 461 - 461
[17] IbrutinibFatigue following off label use: case report
Reactions Weekly, 2019, 1766 (1) : 157 - 157
[18] PaclitaxelHypersensitivity following off label use: case report
Reactions Weekly, 2022, 1910 (1) : 385 - 385
[19] ErdafitinibRetinopathy following off label use: case report
Reactions Weekly, 2021, 1839 (1) : 132 - 132
[20] LiothyronineThyrotoxicosis following off label use: case report
Reactions Weekly, 2022, 1913 (1) : 276 - 276

← 1 2 3 4 5 →